Background -Tiredness and daytime respiratory failure occur frequently in myotonic dystrophy. Sleep hypoxaemia was studied in 12 patients with myotonic dystrophy and correlations were sought with their daytime lung and respiratory muscle function. Methods -All patients underwent overnight sleep studies, clinical assessment, measurement of flow-volume loops and carbon monoxide transfer factor, arterial blood gas analysis, and physiological assessment of both thoracic muscle function and upper airways obstruction. Results -The mean nadir of oxygen saturation during sleep was 75% (95% confidence interval 69% to 81%). A mean of 3-4% of total sleep duration was spent at an oxygen saturation level below 85%.
Abstract
Background -Tiredness and daytime respiratory failure occur frequently in myotonic dystrophy. Sleep hypoxaemia was studied in 12 patients with myotonic dystrophy and correlations were sought with their daytime lung and respiratory muscle function. Methods -All patients underwent overnight sleep studies, clinical assessment, measurement of flow-volume loops and carbon monoxide transfer factor, arterial blood gas analysis, and physiological assessment of both thoracic muscle function and upper airways obstruction. Results -The mean nadir of oxygen saturation during sleep was 75% (95% confidence interval 69% to 81%). A mean of 3-4% of total sleep duration was spent at an oxygen saturation level below 85%. Five of the 12 patients had an apnoea index of >5, the group mean apnoea/ hypopnoea index being 15-8 events/sleep hour. The mean awake arterial oxygen tension (Pao2) was 10-7 kPa. There was a trend to hypercapnoea with a mean awake arterial carbon dioxide tension of 6 1 kPa; carbon dioxide retention worsened during sleep. Respiratory muscle dysfunction was mainly evident as a low maximum expiratory mouth pressure. Upper airway obstruction assessed by physiological criteria was found in four of the 12 patients. The proportion of total sleep duration with oxygen saturation levels below 85% was directly related to body mass index (weight/height2) and inversely related to the awake Pao2. Body Arterial blood gas analyses were performed on the average of two room air samples taken whilst awake and seated, five minutes after local skin infiltration with 1% lignocaine. One sample was collected the night before and the other on the morning after the sleep study. A Radiometer (Copenhagen) ABL300 blood gas analyser was used. One patient refused blood gas sampling.
Respiratory muscle weakness was assessed by three parameters: (1) Peak inspiratory flow (PIF) < 3 1/min. Helium response: ratio of PEF breathing helium to PEF on air > 1 5 measured after three vital capacity breaths of a mixture of 80% helium and 20% oxygen.'3 The flow-volume curves were also inspected for abnormal contours -for example, plateaux or irregular abrupt changes in flow suggesting intermittent airway obstruction.'0 These physiological tests were performed within four weeks of the relevant sleep studies.
Sleep data Sleep data were collected during an overnight inpatient stay in a single room.
Vitalog computerised equipment Version 4.2 (Vitalog Corporation, California, USA) allowed recording of (1) oxygen saturation using a Biox Ohmeda 3700 oximeter; (2) pulse rate from a three lead ECG; (3) thoracic and abdominal excursion via impedance plethysmography; and (4) arm movements. Apnoeas were scored by computer when absent inspiratory movements were present for ) 15 seconds. Hypnoeas were scored when inspiratory excursions were less than two thirds of the concurrent baseline value for at least 15 seconds. There is a strong correlation between this method of identifying hypopnoeas and the 10 second event as scored during polysomnography (Vitalog). Obstructive events were scored when thoracic and abdominal respiratory traces detected paradoxical movements. A validation study of 12 patients by Gyulay et al showed a good correlation of apnoea/hypopnoea index values between a polygraph and a Vitalog system (r=0-70, p<0-01) and all patients with sleep apnoea were correctly diagnosed by the Vitalog system. '4 Transcutaneous carbon dioxide pressures were measured throughout the study night (TCC3 apparatus; Radiometer, Copenhagen, Denmark) and baseline and peak nocturnal levels were read off the resultant printout.
Patient diaries were kept and at least four hours of sleep were recorded in all patients. (74%-86%), MVV12 82% (72%-92%), MIP 84% (62%-106%), and MEP 32% (23%-41 %). Carbon monoxide transfer factor, however, was normal with a mean of 100% predicted (90%-109%) (fig 2) . None of the respiratory function tests was predictive of sleep disordered breathing, awake hypercapnoea, nor of a rise in transcutaneous carbon dioxide pressure during sleep.
Only one of the 12 patients had diaphragm weakness suggested by an FVC value of > 25%. This patient was normocapnoeic while awake and had little sleep hypoxia. 
hypoxia but the correlation with these physiological variables was not significant. The shape of the flow-volume curve was abnormal with plateaux in four of the patients; this did not correlate with any measure of sleep disordered breathing. (Different individuals were in each of the subgroups listed.)
Discussion
The major findings in this study are: (1) that sleep disordered breathing with hypoxia is common in patients with myotonic dystrophy, (2) few patients have symptoms of this, and (3) hypercapnoea is observed while awake and worsens overnight. The mean nadir of oxygen saturation of the group was 75% with 10 of the 12 patients becoming hypoxic overnight. Body mass index and awake Pao2 were predictive of nocturnal hypoxaemia.
A history suggesting sleep apnoea -for example, hypersomnolence or witnessed apnoeas -was given by only one of the group, yet five had an apnoea index of >5. Four others were snorers. Lack of acclimatisation and possibly poor quality sleep may have influenced our results.
A recent paper by Bye et aP reported data on a subgroup of four patients with myotonia who were less well than our group with more hypercapnoea (mean awake Paco2 7 0 kPa) and lower overnight nadir of oxygen saturation (mean 63%). Our study and that of Bye et al show a significant correlation of the nadir of oxygen saturation with BMI and also with awake Pao2. Analysis of the full group of patients with neuromuscular dysfunction in the study by Bye et al showed additional correlates of nadir of oxygen saturation with vital capacity and also with AFVC; neither were demonstrable in our group. Alcohol intake was not likely to contribute to sleep disordered breathing, the mean intake being 20 g/week with a maximum of 70 g/week.
Sudden death is a recognised complication of myotonic dystrophy and is not confined to those with advanced muscle disease. These deaths are often linked to ventricular arrhythmias' and nocturnal hypoxia is a risk factor for these arrhythmias.'5 Intervention with nasal continuous positive airway pressure is warranted in cases of obstructive apnoea showing arterial oxygen desaturation below 75%°.5 The mean nadir of oxygen saturation in our group was 75%.
The only clinical feature we found to correlate with sleep hypoxaemia was obesity. Body mass index was significantly associated with the nadir of oxygen saturation, time spent at saturations below 85%, and the number of 4% drops in oxygen saturation. In contrast, the most sleep disordered cases in the study by Gilmartin et al were not the most obese. 4 These workers showed that myotonic dystrophy was a major risk factor for sleep disordered breathing. They used non-myotonic controls with neuromuscular disease, but the myotonic cohort was more obese than the controls with a mean BMI of 28 (range 25-32) v 23 (range 16-41) respectively. The patients in our study had a mean BMI of 23 (range 17-31). Both of the patients with nadir oxygen saturation values of 60% and 70% respectively had normal BMI values of 21.
Only one of our 12 patients had hypersomnolence and witnessed apnoeas and his nadir of oxygen saturation was 82% with an apnoea/ hypopnoea index of 21 events/sleep hour, these being near the means for our group. Ellis et al have noted that patients with neuromuscular disease may function extremely well in the daytime despite major degrees of obstructive apnoea and severe desaturations during sleep. '7 Respiratory function tests showed a similar pattern to those in previous studies. ' Patients in our group who probably need intervention are those with definite symptoms, prolonged periods spent at low oxygen saturations, and one subject who suffered concurrent moderately severe ischaemic heart disease. Weight control and advice to avoid sedatives seems prudent for all.
Our results suggest that sleep studies may be warranted in patients with myotonic dystrophy, particularly in those who have waking hypoxia or are significantly obese.
